Details for New Drug Application (NDA): 016860
✉ Email this page to a colleague
The generic ingredient in ESKALITH is lithium carbonate. There are fifteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
Summary for 016860
Tradename: | ESKALITH |
Applicant: | Noven Therap |
Ingredient: | lithium carbonate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016860
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 300MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription